CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities
Net income	$ 1,461	$ 23,288
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,562	7,665
Amortization of deferred financing costs charged to interest expense	2,182	664
Stock-based compensation expense	1,922	2,608
Deferred taxes, net	(4,604)	358
Impairment loss of long-lived asset	7,673	0
Changes in operating assets and liabilities
Accounts receivable	6,845	(7,049)
Other assets	1,757	1,387
Accrued payroll	(3,477)	319
Deferred revenue	0	(22,273)
Accounts payable and accrued liabilities	(75)	(5,855)
Other liabilities	1,787	131
Net cash provided by operating activities	31,033	1,243
Investing activities
Business acquisition, net of cash acquired	(180,572)	0
Purchase of equipment and improvements	(625)	(872)
Net cash used in investing activities	(181,197)	(872)
Financing activities
Proceeds from revolving line of credit	205,268	0
Repayment of revolving line of credit	(195,721)	0
Proceeds from debt obligations	168,000	17,000
Repayments of debt obligations	(20,188)	(41,750)
Payments of deferred financing costs	(7,666)	0
Proceeds from issuance of common stock upon exercise of options and warrants	1,108	837
Payment of tax obligations resulting from net exercise of stock options	(650)	(281)
Net cash provided by (used in) financing activities	150,151	(24,194)
Net change in cash	(13)	(23,823)
Cash - beginning of year	228	24,051
Cash - end of year	215	228
Supplemental disclosures of cash flow information
Cash paid during the year for interest	14,153	1,528
Cash paid during the year for income taxes	5,604	9,282
Supplemental disclosures of non-cash activity
Common stock surrendered for the exercise of stock options	$ 238	$ 256